Ryan Glosier

Ryan Glosier

Benzinga Staff Writer

About
Benzinga has allowed me a tremendous platform to explore my passions for trading, investing, startups and venture capital over the years. I was one of the company’s very first employees when Jason Raznick was launching the now ubiquitous financial me...
The Usual Suspects Lead Market Higher Early Thursday – Where To Find Potential Outsized Gains
The U.S. equity market is seeing some strength on Thursday morning after a sell-off on Wednesday. There are a number of large-cap technology-related names that are outperforming thus far on the session on the back of what is likely big money continuing to move into key names.
How To Trade The Whistleblower Revelations About UFOs
News has been making the rounds on Tuesday evening about the intelligence officer whistleblower named David Grusch who has come out and claimed that there are UFO/UAP crash retrieval and reverse-engineering programs nested within DoD and com
Bombshell Whistleblower Testimony Suggests Virgin Galactic Could Be Wildly Undervalued
Shares of Virgin Galactic (NASDAQ: SPCE) are moving aggressively higher in early trade on Tuesday as the world may be about to change in a fundamentally paradigm-shifting way.
Has The Early Weakness In Energy Names Been Erased?
U.S. stocks opened Tuesday’s trading session modestly lower, with the energy sector going from one of the worst-performing sectors to one of the best in the first 15 minutes. The SPDR Select Sector SPDR Fund (NYSEARCA: XLF) had opened around 1.70% lower, but as of this writing was trading down just 0.33% despite mildly bearish price action in the S&P 500. 
Is This The Most Wildly Bullish Chart On The NASDAQ?
The U.S. stock market in today’s times offer everything a trader would want. There are 4,000 symbols listed on the NYSE and NASDAQ and trading commissions are a thing of the past – even if Citadel Securities is scraping pennies on millions of orders – and overall, it’s undeniably a good thing.
Have Poor Q1 Earnings Set Up A Short Opportunity In These Two Brick-And-Mortar Retailers?
The two leading dollar-store stocks seem to have come crashed heavily in recent days and may be setting up for continued weakness, presenting an opportunity for a quick play on the short side.
Bill Miller IV Isn't Chasing Nvidia In Its $1-Trillion Days: 2 Stock Ideas From The Money Manager
The son of legendary value investor Bill Miller appeared on CNBC’s "Closing Bell" Wednesday to discuss the transition in ownership at Miller Value Partners and some stock views and ideas.
Trading Regional Banks – Is The Crisis Really Over?
Heading into Wednesday’s trading session, regional banks continue to look incredibly vulnerable from the short side and any weakness should be aggressively pounced upon by traders.
How To Trade Nvidia This Week
From a psychological standpoint, the hottest stock in the market, Nvidia (NASDAQ: NVDA), is hovering around two key levels heading into Wednesday’s trading session.
Short Sellers Are Still Targeting Brick-And-Mortar Retailers – Should You Too? A Look At DDS And GME
The “sell everything brick and mortar” theme has been playing out on Wall Street for the better part of a decade and the casualties have absolutely piled up, with Bed Bath and Beyond being the latest.
Regional Banks Remain On Life Support
Last week saw a number of brutal days for regional bank stocks with that sector swinging wildly amid otherwise modest gains on Wall Street. Despite the best hopes of investors and observers alike, the issue in the U.S.
Value Investing: Three Dirt Cheap Stocks
Walter J. Schloss is a name that may ring bells with value investors as he was deemed a “super-investor” by none other than Warren Buffett in a famous essay entitled “The Superinvestors of Graham-and-Doddsville,” which was published in the Columbia University Business School magazine back in 1984.
Drug Data Sends ImmunoGen (NASDAQ: IMGN) To Multi-Year Highs, Up 150% In Two Days
Shares of biotech firm ImmunoGen (NASDAQ: IMGN) are surging for a second straight day after the company reported positive ovarian cancer drug data on Wednesday. At last check, the stock was up nearly 11% to $13.56 on very elevated volume.
Wolfspeed Technical Outlook After Last Thursday's Big Plunge – The Drop Continues
Here is the technical outlook for Wolfspeed Inc. (NYSE: WOLF) for this week – this stock is finished! Hyperbole aside, despite the previous Thursday’s massive sell-off, this stock is continuing to set up on the short side.
Meta Platforms Technical Outlook: A Checkered Flag? Stock Seems Set Up For Continued Run
The big story on Wall Street on Wednesday afternoon has been Facebook’s parent, Meta Platform’s (NASDAQ: META),
Three Swing-Trade Shorts With Significant Catalysts
Do not let the headline numbers on the Dow, S&P and Nasdaq on Wednesday fool you – we are seeing a second consecutive day of market weakness despite only modest losses thus far for the Dow and S&P and a jump of 0.7% in the Nasdaq. The entire U.S.
3 Long-Term Brand Bets With A Great Track Record That Display Significant Potential
Throughout his legendary investing career, Warren Buffett has always stressed the importance of seeking out companies that have a durable competitive advantage and, similarly, an impenetrable brand moat.
Potential Breakout Setups To Watch On Wednesday
The U.S. stock market has weakened throughout Tuesday’s trading session and the major indices were sitting near session lows heading into the closing bell.
Semiconductors And Consumer Cyclical Stocks Lead Tuesday's Sell-Off; Stocks To Watch Wednesday
The U.S. stock market closed on Tuesday at session lows, breaking through a short-term trading range to the downside.
Looking For Shorts? Check Out This List Of Names Exhibiting Significant Weakness
Traders across Wall Street have been gunning for a downturn in U.S. stocks, which have been surprisingly resilient in recent weeks despite numerous headwinds. On Tuesday, broad-based indices are showing some weakness while defensive sectors have been rallying modestly.